CCMI
TECH icon

Creative Capital Management Investments’s Bio-Techne TECH Stock Holding History

Creative Capital Management Investments’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.84K Buy
+26
New +$1.4K ﹤0.01% 844

Other funds holding TECH

FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
OTL
Oak Thistle LLC New York $1.03B AUM 26.06% 1-Year Est. Return
PAM
Palisade Asset Management Minneapolis, Minnesota $1.08B AUM 22.62% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Creative Capital Management Investments's TECH Position: Q2 2026 in Review

Creative Capital Management Investments opened a new position in Bio-Techne (TECH) in Q2 2026: 26 shares worth $1.84K. The stake represents ﹤0.01% of the portfolio and ranks #844 among its holdings.

117 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Creative Capital Management Investments held 26 shares of Bio-Techne worth $1.84K as of Q2 2026.
  • Bio-Techne was a new Creative Capital Management Investments position in Q2 2026.
  • Bio-Techne made up ﹤0.01% of Creative Capital Management Investments's portfolio in Q2 2026, its #844 holding.
  • 117 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Creative Capital Management Investments's 13F filing for Q2 2026, filed 24 Jul 2026.